GENE-MODIFIED CANCER VACCINE: A PHASE I STUDY 
<0 
0 ) 
C 
0 
•u 
• H 
i* 
0 ) 
Cl *h 
<0 in 
Li 3 
4J 43 
c c 
u 
T3 <D 
0) U 
•H C 
43 re 
•H O 
T3 
O C 
x re 
L M 
in 
>, 
10 
CD T5 
u 
' t- 
CT' 
■X Li 
\ 0 
U ffL 
C E 
<0 > 
OlflH 
u 
Li 
L (1) 
0 U 
c 
' <0 
►h o 
►3 
c 
» (0 
hH — 1 
L 
0) 10 
ty > 
io o 
43 
to 
V 
oi >1 
■p a 
a> io 
rH L 
a ai 
e £ 
O 43 
u o 
E 
0 ) 0 ) 
> £ 
U 
T3 
C 
10 
>1 
Li 
0) 
O' 
Li 
3 
CO 
in 
10 
oi O' 
in (0 
•h E 
a m 
(0 
Li 
0 
Li 4-> 
0) C 
x 0) 
1 in 
re oi 
r l 
a 
Li 
O 0) 
E 43 
3 
H 43 
in 
>. 3 
43 £ 
O 
C3 
® 
c 
•w 
o 
o 
0 
> 
Li 
® 
o 
c 
a 
C3 
e 
0 
•H 
Ll 
0 
► 
o 
•a 
« 
re: 
0 
X 
1 
O 
c 
O 
o 
43 
—4 
re 
U 
-4 £ 
E 
X 
re £ 
•H O' 
L 
01 
O 43 
3 3 
O 
rH 
•H 
0 
c 
in 
a 
pH 
£ 3 
in l 
re 
E 
pH 
43 
—4 43 
4-1 
£ 
•H 
0 ) 
•H C 
i—4 43 
0 
10 
0 
3 0 ) 
® 
4 
> 
O TJ 
u 
H 
in 
< T3 -H 
0) 
u 
1 
o> 
01 D'4-I Ll 
< 
a 
3 
0 0) 
o 
CL 
L 
•• 
o in 
43 
o 
0 ) 
ft 
C 
pH *H 
® in 
o 
* 
X 
x: 
0 
pH 
in -h 
rH 
0 ) 
H 
•H 
0 ® 
o c 
c 
O 
to 
43 
43 in "o -h 
c 
•—1 
£ 
l 
0 
0 
E 
•H 
J 44 
rH 
Ll 
0) *0 T5 "D 
1 
43 
43 
o> re 
Li 
pH 
in 
< 
n 
Li 
c 
0 
pH 
in 
a 
-H 
-4 0) 
tyo 43 
01 
o> 
c 
-4 £ 
•H c 
0 ) 
u 
L 
m. 
•H 
•h 04 w <o 
43 
a ® 
a 
3 -4 
in 
43 
10 
X 
in 
43 
re tj 
re 
e 
0 ) 
re 
< 
C 
01 
0 
0 
c 
re re 
® 43 
c 
0 
•H 
w 
-4 
£ re 
f-4 
•H 
43 
x: 
c 
a 43 
&4 -H 
re 
o 
0 
re 
*0 
0 
L T3 
0 ) 
C £ 
re 
c 
re 
0 ) 
c 
o 
O 43 
• Ll 
o 
O 
u 
■H 
cr 
•H 
in 
43 
3 *D 
0 
43 £ 
o - 
•H 
c 
T3 
•H 
n 
re u 
-4 T> 
Li 
re 
in 
E 
0 
—4 3 
u o 
0 
•H 
c 
Sh 
Q 
re in 
L 
a 
Ll 
re 
43 
u 
u re 
re 
re 
L H 
O 
in 43 
a L 
> 
43 
c 
® c 
43 o 
43 
o 
in 
•H 
0 ) 
re Li 
C 
c 
3 
O 
0) -H 
Q) Q* -H 
0 ) 
O 
Ll 
O 
in 43 
a 
£ 
0) 
-H 
0 
o re 
01 0 ) 
c 
H 42 
> 
► 
v a L £ 
re 
E 
re 
c 
>ft 
Li 
re 
pH 
c 
O' 
•— 
C H L 
re 
0 
Ll 
re re -h 
pH 
0 
13 
Ll 
re 
T3 
•H 0) > 
pH 
•H 
a 
H 
> 
c 
43 
Li CO 
0) 
£ 
o 
0 
re 
C 
re o-4 
0 
0 
0 
0 
o 
> in 43 0 
•H 
1-4 
c 
pH 
pH 
> 
E 
O *H »H *H 
E 
4= TJ 
0 
•H 
re 
re 
43 
43 
L 13 
3 
0) 
c 
V 
0 
3 
O 
rarer j) c 
E 
L 
3 
13 
•H 
V 
<4H 
0) 
oi i3 a re 
•H 
0 
0 
E 
re 
c 
— 
re 
L 
*h *h re O' 
X 
c 
43 
• 
E 
> 
•H 
in 
in 
43 
43 £ Ll 
re 
•pH 
in 
Sh-h 
pH 
o 
•H 5 43 >, 
E 
0 
•H 
pH 
in 
u 
Li 
o 
iw 
V C £ 
u 
c 
pH 
0) 
•H 
£ 
O 
0 0 -H 
re 
re 
•H 
re 
£ 
£ 
Li 
o 
43 
£ C -O 
> 
E 
0 
43 
43 
o 
£ 
in 
1 -H >o 0) 
® 
T> 
c 
43 
43 
0) 
43 
O 13 O 43 
c 
o 
re 
0 
® 
O 
43 
13 
C 13 L re 
•H 
£ 
43 
43 
43 
c 
re 
O 
o re o > 
E 
43 
01 
*H 
re 
f> 
0 
3 
43 
U > 43 -H 
L 
£ 
in 
3 
0) 
Li 
pH 
43 
in 43 
0) <*H 
0> rH 
in 
01 
in 
re 
O 
re l -h u 
43 
0 
>ft a re 
c 
in 
43 
> 
o c re 
O 
pH 
re 
> 
o 
£ 
0 
0 
0) 
£ 0 -h 
■o 
0 
0 
L 
0 
Q 
0 
0 
X! 
43 C E >0 
in 
43 
43 
in 
43 
0 
•H 
■4 re re c 
0 
0 
re 
C 
0 
0 
0 
43 
E- 1 
in 
5 U re re 
H V 
in 
•H 
H 
Ll 
H 
0 
Li 
0) 
U 
C 
re 
O 
[572] 
Recombinant DNA Research, Volume 15 
